RegulatoryJun 5, 2026, 04:37 PM
Humacyte Regains Nasdaq Compliance with $1.00 Bid Price Rule
AI Summary
Humacyte, Inc. announced that it has regained compliance with The Nasdaq Global Select Market's minimum $1.00 per share bid price requirement. The company had previously received a notification on May 4, 2026, regarding non-compliance. Nasdaq confirmed on June 5, 2026, that Humacyte met the requirement, closing the matter.
Key Highlights
- Humacyte received initial Nasdaq notification on May 4, 2026, for non-compliance with the $1.00 minimum bid price rule.
- The company was required to maintain a closing bid price of $1.00 or more for 10 consecutive business days by November 2, 2026.
- On June 5, 2026, Humacyte received a letter from Nasdaq confirming it had regained compliance.
- Nasdaq considers the minimum bid price requirement matter closed.
Price Impact
More from HUMA